$AZN News Article - Capivasertib plus FASLODEX (f
Post# of 85
(Total Views: 190)
Posted On: 10/26/2022 2:50:56 PM
$AZN News Article - Capivasertib plus FASLODEX (fulvestrant) significantly improved progression-free survival vs. FASLODEX in CAPItello-291 Phase III trial in advanced HR-positive breast cancer https://marketwirenews.com/news-releases/capi...41525.html
(0)
(0)AstraZeneca PLC (AZN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼